CLEARGEE

This brand name is authorized in Nigeria.

Active ingredients

The drug CLEARGEE contains one active pharmaceutical ingredient (API):

1	Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100761	Cream	CLEARGEE CREAM CREAM 0.05% 1 X 30G	22 NF-PP-369788 CLEARGEE CREAM BETAMETHASONE DIPROPIONATE USP 0.05% W/W EACH 30G TUBE CONTAINS BETAMETHASONE DIPROPIONATE USP EQ TO BETAMETHASONE 0.05% W/W EXCIPIENTS CREAM BASE A4-100761 Drugs Imported Products 1X30G POM 1 9/28/2023 SUITELIFE PHARMACEUTICALS LTD, 4 ayo davis close off ekolonu street, surulere, lagos 8129419809 suitelifepharma@yahoo.com SYSTOCHEM LABORATORIES LTD, B-75, ROOP NAGAR, INDL. AREA, LONI-201 102. INDIA, India	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC01	Betamethasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100761